Key points are not available for this paper at this time.
Thomas J Dougherty from Roswell Park Cancer Center played a major role in the progress of photodynamic therapy (PDT) from a laboratory science into a real-world clinical therapy to treat patients with cancer. Nevertheless over the succeeding 45 years, it is fair to say that the overall progress of clinical PDT for cancer has been somewhat disappointing. The goal of this perspective article is to summarize some of the clinical trials run by various companies using photosensitizers with different structures that have been conducted for different types of cancer. While some have been successful, others have failed, and several are now ongoing. I will attempt to touch on some factors, which have influenced this checkered history and look forward to the future of clinical PDT for cancer.
Building similarity graph...
Analyzing shared references across papers
Loading...
Michael R. Hamblin
Vascular Medicine
Photochemistry and Photobiology
Harvard University
Massachusetts General Hospital
University of Johannesburg
Building similarity graph...
Analyzing shared references across papers
Loading...
Michael R. Hamblin (Tue,) studied this question.
synapsesocial.com/papers/6a033e991abe013fb89e4176 — DOI: https://doi.org/10.1111/php.13190